Ref.: BL-RE-093059Manufacturer ref.: EH291RBX5 5 x 96 tests
€2,950.00 excl. VAT
Human LAIR1 quantitates human LAIR1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LAIR1.
Accession number
5133400O11Rik; BB115266; CD305; D7Bwg0421e; variable, heavy chain region of immunoglobulin; Lair1; LAIR-1; leukocyte-like receptor 1; leukocyte-like receptor 1; leukocyte-like receptor 1; leukocyte-like receptor 1; leukocyte-like receptor 1; rLAIR1
Dose range
0.6 to 130 ng/ml
Sensitivity of the dosage
0.6 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human LAIR1 quantitates human LAIR1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LAIR1.
Human LAIR1 quantitates human LAIR1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LAIR1.
LAIR1 (CD305) works as an inhibitory receptor that plays a negative regulating role that is constitutive to the cytolytic function of natural killer cells (NK), B cells and T cells. Tyrus phosphorylation activation results in the recruitment and activation of PTPN6 and PTPN11 phosphatases. It also reduces the increase in intracellular calcium caused by the ligature of B-cell receptors. It can also act as an inhibitor independently of SH2-containing phosphatases. Modules the production of cytokine in CD4+ T cells, the production of IL2, and d的IFNG regulated downwards, while inducing secretion of the transformant beta growth factor. Also lowers the production of IgG and d-IgE in B cells, as well as secretion of IL8, IL10 and TNF. Inhibits proliferation and induces apoptosis in myeloid leukemic cell lines and prevents nuclear translocation of the NF-kappa-B p65/RELA subunit and phosphorylation of the I-kappa-B alpha/CHUK in these cells. Inhibits differentiation of precursors from peripheral blood to dendritic cells.
Sensitivity
Sensitivity of dosage: 0.6 ng/ml.
Measurement range
Dose range: 0.6 to 130 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: LAIR1 (CD305).
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17155059
Specifications
Accession number
5133400O11Rik; BB115266; CD305; D7Bwg0421e; variable, heavy chain region of immunoglobulin; Lair1; LAIR-1; receptor similar to l-immunoglobulin associated with leukocytes 1; receptor similar to l-Ig associated with leukocytes 1; receptor similar to l-Ig associated with leukocytes 1; rece